Luna-Garza R

Language: Spanish
References: 18
Page: 69-76
PDF size: 294.24 Kb.

ABSTRACT

Background: Because the sudden hearing loss is a condition considered a medical emergency, it is important to diagnose it in time to start treatment. One of the probable causes of this condition is the formation of microthrombi, these may be associated with the presence of anticardiolipin antibodies. There is evidence in the literature that there is association between progressive sensory hearing loss of unknown origin and sudden hearing loss with elevated anticardiolipin antibodies.
Objective: To determine whether association between the presence of sudden hearing loss with elevated anticardiolipin antibodies in patients with this condition assisted at Hospital Juárez de México.
Material and method: A descriptive, longitudinal and prospective study was made, in which after the clinical diagnosis of sudden hearing loss, a tonal audiometry was done, that evaluated the auditory function assessing the air and bone way to confirm the diagnosis, and anticardiolipin antibodies IgG and IgM were requested. Results were assessed in posterior consultations.
Results: Samples for anticardiolipin antibodies were taken in 15 patients. Average age was 50 years. None patient had bilateral sudden hearing loss at diagnosis. Results of anticardiolipin antibodies of 15 patients were normal.
Conclusions: This study did not find elevation of anticardiolipin antibodies, maybe it is needed a bigger sample to find some association, besides, four patients assisted to different laboratories, thus, measure technique may vary, influencing results.

REFERENCES

1. Byl FM. Sudden hearing loss: eight years experience and suggested prognostic table. Laryngoscope 1984;94:647- 661.

2. O’Mailey MR. Sudden hearing loss. Otolaryngol Clin N Am 2008;41:633-649.

3. Bayley BJ. Head and neck surgery–otolaryngology. 4th ed. Philadelphia: Lippincott Willams and Wilkins, 2006;2232- 2236.

4. Fetterman BL. Sudden bilateral sensorineural hearing loss. Laryngoscope 1996;106:1347-1350.

5. Mattox DE. Idiopathic sudden sensorineural hearing loss. Am J Otol 1989;10:242-247.

6. Byl FM. Diagnosis and treatment of sudden–onset sensorineural hearing loss: a ten years retrospective analysis. Otol Neurotol 2003;24:728-733.

7. Haynes DS, Malley MO. Intratympanic dexametasona for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007;117:3-15.

8. Conlin AE. Treatment of sudden sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2007;133:582-586.

9. Battista RA. Intratympanic dexamethasone for profund idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2005;132:902-905.

10. Parnes LS, Sun AH Freeman DJ. Coriticoesteroides: pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999;109:1-17.

11. Kopke RD. Targetd topical steroid therapy in sudden sensorineural loss. Otol Neurotol 2001;22:474-479.

12. Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 2001;22:18-23.

13. Mouadeb DA. Antiphospholipid inner ear syndrome. Laryngoscope 2005;115:879-883.

14. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-763.

15. Randolph C. Sudden hearing loss: an update. Am J Otol 1998;9:211-215.

16. McCabe B. Autoimmune sensorineural hearing. Ann Otol Rhinol Laryngol 1979;88:585-589.

17. Aslan A, De Donato G. Clinical observations on coexistence of sudden hearing loss and vestibular schwannoma. Otolaryngol Head Neck Surg 1997;117:580-582.

18. Toubi E, Ben-David J, Kessel A. Autoimmune aberration in sudden sensorineural hearing loss: association with anticardiolipin antibodies. Lupus 1997;6:540-542.